CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.
Peter Borchmann, M.D.
Advertisement
Articles by Peter Borchmann, M.D.
Advertisement
Latest Updated Articles
CAR T-Cell Therapy Offers Hope in DLBCLPublished: July 10th 2018 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
2
Tagrisso Plus Chemo Offers Survival benefit in EGFR+ NSCLC
3
Finding Love and Humanity in the Radiation Waiting Room
4
Quality of Life Maintained with Akeega Combo in Prostate Cancer
5
